Early Access — free while we kick the tires
EdgarHawk

Christine Marie Utter

SVP, CHIEF ACCOUNTING OFFICER

Officer

Latest: SVP, CHIEF ACCOUNTING OFFICER selling · June 2026

1 filing analyzed · 1 company · Latest 2026-06-22

Companies

Company Buys Sells Direction
PTC THERAPEUTICS, INC. PTCT 0 2 Net selling

Activity

June 2026
2026-06-22 PTC THERAPEUTICS, INC. PTCT
medium
Sell
19,686 shares
$1,487,474
Significance 5/10

SVP/Chief Accounting Officer Christine Marie Utter sold 19,686 shares of PTCT at $75.56 under pre-arranged 10b5-1 plan; retains 70,199 shares plus 15,314 stock options

Christine Marie Utter, Chief Accounting Officer, sold 19,686 shares (19.7K shares) for $1,487,474.16 ($1.5M) on 2026-06-17 at $75.56 as part of a scheduled 10b5-1 trading plan adopted 2026-03-17. The stock has since risen to $80.96 (current price), though remains -7.5% from its 52-week high of $87.50. Post-transaction, Utter retains 70,199 non-derivative shares plus 15,314 shares through stock options, indicating a partial reduction rather than an exit. PTCT has delivered substantial growth: annual revenue increased 114.5% year-over-year to $272.6M in the latest quarter, though the company reported a net loss of $2.8M. The scheduled nature of this sale—locked in via pre-arranged plan three months prior to execution—removes discretionary timing as a signal; investors should focus on the company's operating fundamentals (strong topline growth offset by current-quarter profitability challenges) rather than on the insider's trade timing or conviction.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access